Jushi Holdings Director Granted 100,000 Stock Options
Jushi Holdings Inc.
Subscribe to track JUSH/JUSHF
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Jushi Holdings Director Granted 100,000 Stock Options
Company: Jushi Holdings Inc. (JUSH/JUSHF) Form: 4 | Filed: 2025-12-15 Significance: Low
Insider: MARINA HAHN Title: null | Relationship: Director
Transaction: • Type: Grant (Stock Options) • Shares: 100,000 • Price: $0.00 • Value: $0 • Owned After: 100,000 options
Key Insight: A director received a routine equity compensation grant of 100,000 stock options. These options have an exercise price of $0.50 and vest over three years.
Market Context: This is a standard compensation event and not an open-market transaction, providing a weak signal about insider sentiment.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: Jushi Holdings Inc. (JUSH/JUSHF)
Executive Summary
- Trading Significance: Low
- Key Takeaway: A director, Marina Hahn, was granted 100,000 stock options as part of a standard compensation package.
- Market Impact: Neutral. This is a routine, non-market transaction and is not indicative of a specific insider sentiment shift.
Company Information
| Field | Value |
|---|---|
| Company | Jushi Holdings Inc. |
| Ticker Symbol | JUSH/JUSHF |
| CIK | 0001909747 |
| Industry | Medicinal Chemicals & Botanical Products |
Insider Information
| Field | Value |
|---|---|
| Name | MARINA HAHN |
| CIK | 0001020975 |
| Title/Position | null |
| Relationship | Director |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 4 |
| Transaction Date | 2025-12-11 |
| Transaction Code | A (Grant) |
| Security Type | Stock Option (right to buy) |
| Shares Involved | 100,000 |
| Price Per Share | $0.00 |
| Total Value | $0 |
| Shares Owned After | 100,000 (options) |
| Ownership Type | Direct |
Financial Impact Assessment
Impact Evaluation
- Transaction Significance: The transaction is a grant of stock options with a reported value of $0, making its immediate financial impact negligible. The potential value is contingent on the company's stock price rising above the $0.50 exercise price before the 2035 expiration date. As a form of compensation, it is considered a routine event with low trading significance.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: Equity grants to directors are a common form of compensation and do not represent an insider's decision to buy or sell shares on the open market. Therefore, this event is unlikely to influence stock price.
Volume & Sentiment
- Expected Volume Impact: None. No shares were traded on the open market.
- Sentiment Indicator: Neutral. The grant aligns incentives but does not signal new information about the company's near-term prospects.
Additional Context
Transaction Notes
- Vesting Schedule: The options vest in three equal installments on December 11 of 2026, 2027, and 2028, contingent upon the director's continuous service.
- Option Details: These are derivative securities granting the right to buy 100,000 Subordinate Voting Shares at an exercise price of $0.50 per share. They expire on December 11, 2035.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.